Graeme Meintjes Selected Research

Highly Active Antiretroviral Therapy (HAART)

12/2023	Myocardial extracellular volume fraction is positively associated with activated monocyte subsets among cART-treated persons living with HIV in South Africa.
7/2012	Immune reconstitution inflammatory syndrome in a large multicenter cohort study: case definition and comparability.
3/2012	Immunological characterisation of an unmasking TB-IRIS case.
6/2009	Neurologic manifestations of paradoxical tuberculosis-associated immune reconstitution inflammatory syndrome: a case series.
3/2009	Novel relationship between tuberculosis immune reconstitution inflammatory syndrome and antitubercular drug resistance.
11/2008	Type 1 helper T cells and FoxP3-positive T cells in HIV-tuberculosis-associated immune reconstitution inflammatory syndrome.
7/2008	Prevention and treatment of the immune reconstitution inflammatory syndrome.
10/2006	Dermatologic manifestations of the immune reconstitution inflammatory syndrome.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Graeme Meintjes Research Topics

Disease

93	Tuberculosis (Tuberculoses) 05/2024 - 02/2006
43	Immune Reconstitution Inflammatory Syndrome 07/2023 - 10/2006
40	Cryptococcal Meningitis 01/2023 - 10/2006
26	Infections 02/2023 - 09/2009
15	Multidrug-Resistant Tuberculosis (Drug-Resistant Tuberculosis) 10/2023 - 09/2010
12	Coinfection 01/2022 - 01/2013
11	HIV Infections (HIV Infection) 11/2021 - 01/2008
10	Acquired Immunodeficiency Syndrome (AIDS) 10/2020 - 07/2012
9	Meningeal Tuberculosis (Tuberculous Meningitis) 09/2023 - 12/2013
8	Opportunistic Infections (Opportunistic Infection) 04/2020 - 08/2007
7	Inflammation (Inflammations) 01/2023 - 12/2013
6	Anemia 01/2023 - 07/2008
6	Pulmonary Tuberculosis 01/2021 - 11/2013
5	Body Weight (Weight, Body) 01/2022 - 03/2014
4	Meningitis 01/2018 - 01/2014
4	Clinical Deterioration 01/2013 - 10/2006
3	COVID-19 02/2023 - 11/2020
3	Lymphadenopathy 01/2022 - 01/2020
3	Sepsis (Septicemia) 01/2022 - 01/2017
3	Necrosis 10/2020 - 06/2009
3	Extensively Drug-Resistant Tuberculosis 12/2018 - 01/2014
2	Cough 01/2022 - 01/2022
2	Cryptococcosis 01/2022 - 11/2020
2	Respiratory Insufficiency (Respiratory Failure) 11/2020 - 03/2018
2	Pneumonia (Pneumonitis) 11/2020 - 03/2018
2	Hydrocephalus (Hydrocephaly) 04/2020 - 10/2017
2	Systemic Inflammatory Response Syndrome (Sepsis Syndrome) 01/2019 - 12/2015
2	Bacterial Infections (Bacterial Infection) 11/2018 - 01/2009
2	Neoplasms (Cancer) 11/2018 - 08/2016
2	Communicable Diseases (Infectious Diseases) 01/2018 - 10/2015
2	Chemical and Drug Induced Liver Injury 01/2016 - 03/2012
2	Disease Progression 10/2015 - 02/2015
2	Vitamin D Deficiency 08/2014 - 10/2012
2	Central Nervous System Diseases (CNS Diseases) 01/2013 - 11/2010
1	Heart Failure 12/2023
1	Fibrosis (Cirrhosis) 12/2023
1	Cardiotoxicity 01/2023
1	Viremia 01/2023
1	Leprosy (Hansen's Disease) 01/2023

Drug/Important Bio-Agent (IBA)

28	Rifampin (Rifampicin)FDA LinkGeneric 05/2024 - 02/2006
20	AntigensIBA 01/2023 - 02/2006
17	lipoarabinomannan (LAM)IBA 01/2023 - 07/2014
16	Fluconazole (Zonal)FDA LinkGeneric 01/2023 - 10/2006
14	CytokinesIBA 01/2023 - 07/2007
13	Linezolid (Zyvox)FDA Link 09/2023 - 01/2014
12	Prednisone (Sone)FDA LinkGeneric 05/2024 - 09/2010
12	Amphotericin B (Amphotericin)FDA LinkGeneric 12/2022 - 07/2007
11	bedaquiline (R207910)IBA 10/2023 - 01/2014
10	Isoniazid (Ftivazide)FDA LinkGeneric 01/2022 - 02/2006
7	Adrenal Cortex Hormones (Corticosteroids)IBA 05/2024 - 06/2009
7	Flucytosine (Ancobon)FDA Link 01/2023 - 07/2008
7	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2017
6	liposomal amphotericin B FDA Link 01/2023 - 06/2015
5	C-Reactive ProteinIBA 06/2023 - 01/2021
5	VaccinesIBA 02/2023 - 12/2010
5	deoxycholate drug combination amphotericin BIBA 01/2023 - 12/2015
5	ChemokinesIBA 01/2023 - 10/2012
5	InterleukinsIBA 01/2021 - 08/2015
4	Clofazimine (Lamprene)FDA Link 01/2023 - 12/2018
4	Interleukin-6 (Interleukin 6)IBA 01/2023 - 06/2009
4	dolutegravirIBA 01/2023 - 01/2020
4	Pyrazinamide FDA LinkGeneric 01/2022 - 10/2016
4	Hemoglobins (Hemoglobin)IBA 01/2022 - 03/2014
4	Matrix Metalloproteinases (MMPs)IBA 01/2018 - 05/2012
3	Proteins (Proteins, Gene)FDA Link 12/2023 - 01/2017
3	Anti-Bacterial Agents (Antibiotics)IBA 01/2023 - 03/2012
3	Antitubercular AgentsIBA 01/2022 - 01/2009
3	FluoroquinolonesIBA 01/2022 - 01/2018
3	Interleukin-17 (Interleukin 17)IBA 01/2021 - 01/2016
3	Lactic Acid (Lactate)FDA LinkGeneric 01/2020 - 12/2015
2	Levofloxacin (Levaquin)FDA Link 05/2024 - 12/2018
2	N-(2-cyanoethylene)urea (BA 1)IBA 02/2023 - 07/2022
2	Integrase InhibitorsIBA 01/2023 - 01/2022
2	Interleukin-8 (Interleukin 8)IBA 01/2023 - 10/2012
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2023 - 01/2021
2	Dihydrotachysterol (AT 10)IBA 01/2022 - 03/2014
2	chinese inkIBA 01/2022 - 01/2014
2	Raltegravir Potassium FDA Link 01/2021 - 01/2021
2	GlucocorticoidsIBA 11/2018 - 09/2010
2	InflammasomesIBA 01/2017 - 09/2015
2	InterferonsIBA 11/2016 - 06/2012
2	Interleukin-10 (Interleukin 10)IBA 11/2016 - 01/2016
2	hydroxide ionIBA 08/2014 - 10/2012
2	Interferon-gamma (Interferon, gamma)IBA 09/2009 - 06/2009
2	EnzymesIBA 11/2008 - 02/2006
1	GadoliniumIBA 12/2023
1	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 01/2023
1	AntibodiesIBA 01/2023
1	Fluorescent Dyes (Fluorescent Probes)IBA 04/2022
1	Carbapenems (Carbapenem Antibiotics)IBA 01/2022

Therapy/Procedure

64	Therapeutics 01/2023 - 10/2006
35	Art Therapy 01/2022 - 01/2008
8	Highly Active Antiretroviral Therapy (HAART) 12/2023 - 10/2006
5	Injections 01/2022 - 01/2018
3	Aftercare (After-Treatment) 01/2022 - 01/2017
2	Lasers (Laser) 01/2023 - 01/2021
2	Treatment Delay 01/2021 - 01/2020
2	Immunotherapy 11/2020 - 06/2012
2	Ventriculoperitoneal Shunt 04/2020 - 10/2017
2	Drug Therapy (Chemotherapy) 10/2019 - 01/2009